Goodwin Procter advised a syndicate of investors on the deal. Bird & Bird advised SparingVision. SparingVision, a genomic medicines company with a mission to translate pioneering...
SparingVision’s €75 Million Series B Financing
Intellia Therapeutics’ Acquisition of a Stake in SparingVision
IN BRIEF: Bird & Bird, Foley Hoag LLP, Goodwin Procter, advised on the matter. Bird & Bird advised SparingVision SAS with a team including Emmanuelle Porte...